|
Lynch, D R; Shim, S S; Seifert, K M et al. (2001) Pharmacological characterization of interactions of RO 25-6981 with the NR2B (epsilon2) subunit. Eur J Pharmacol 416:185-95
|
|
Anegawa, N J; Guttmann, R P; Grant, E R et al. (2000) N-Methyl-D-aspartate receptor mediated toxicity in nonneuronal cell lines: characterization using fluorescent measures of cell viability and reactive oxygen species production. Brain Res Mol Brain Res 77:163-75
|
|
McCormack, M L; Guttmann, R P; Schumann, M et al. (2000) Frataxin point mutations in two patients with Friedreich's ataxia and unusual clinical features. J Neurol Neurosurg Psychiatry 68:661-4
|
|
Shim, S S; Grant, E R; Singh, S et al. (1999) Actions of butyrophenones and other antipsychotic agents at NMDA receptors: relationship with clinical effects and structural considerations. Neurochem Int 34:167-75
|
|
Gallagher, M J; Huang, H; Lynch, D R (1998) Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B-specific interactions. J Neurochem 70:2120-8
|
|
Gallagher, M J; Huang, H; Grant, E R et al. (1997) The NR2B-specific interactions of polyamines and protons with the N-methyl-D-aspartate receptor. J Biol Chem 272:24971-9
|
|
Gallagher, M J; Huang, H; Pritchett, D B et al. (1996) Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 271:9603-11
|
|
Lynch, D R; Gallagher, M J (1996) Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors. J Pharmacol Exp Ther 279:154-61
|
